Innospec

Elementis Rebuffs Innospec Approach

UK specialty chemicals company Elementis has been the subject of another attempted takeover – its fourth in under six months – but this time from US rival, Innospec.

News

Innospec Says Expects To Settle Bribe Probes

Top-Feature

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

CHEManager International c/o Wiley-VCH GmbH

20 Years of CHEManager International

CHEManager International c/o Wiley-VCH GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Hamilton Bonaduz AG

Optimize Your Process with Smart Oxygen Sensors for Inertization and Blanketing Applications

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

Free Expert Insights

Advancements in Bispecific Antibody Development

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

The Valence Group